Differences in efficacy and safety among CAR-Ts anti-CD19/CD22, anti-CD19, and anti-CD22, in adult patients with relapse/refractory B-cell acute lymphoblastic leukemia: a meta-analysis and systematic review.
Saved in:
| Title: | Differences in efficacy and safety among CAR-Ts anti-CD19/CD22, anti-CD19, and anti-CD22, in adult patients with relapse/refractory B-cell acute lymphoblastic leukemia: a meta-analysis and systematic review. |
|---|---|
| Authors: | Becerril-Rico J; Subdirección de investigación Básica, Instituto Nacional de Cancerología, Secretaría de Salud, Ciudad de México, México.; Programa de posgrado en Ciencias Biológicas, Universidad Nacional Autónoma de México, Ciudad de México, México., Delgado-Montes YA; Centro Médico Nacional La Raza, Instituto Mexicano del Seguro Social, Ciudad de México, México., Ortiz-Sánchez E; Subdirección de investigación Básica, Instituto Nacional de Cancerología, Secretaría de Salud, Ciudad de México, México. |
| Source: | Leukemia & lymphoma [Leuk Lymphoma] 2023 Nov-Dec; Vol. 64 (11), pp. 1822-1831. Date of Electronic Publication: 2023 Aug 07. |
| Publication Type: | Meta-Analysis; Systematic Review; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37548560 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Differences in efficacy and safety among CAR-Ts anti-CD19/CD22, anti-CD19, and anti-CD22, in adult patients with relapse/refractory B-cell acute lymphoblastic leukemia: a meta-analysis and systematic review. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Becerril-Rico+J%22">Becerril-Rico J</searchLink>; Subdirección de investigación Básica, Instituto Nacional de Cancerología, Secretaría de Salud, Ciudad de México, México.; Programa de posgrado en Ciencias Biológicas, Universidad Nacional Autónoma de México, Ciudad de México, México.<br /><searchLink fieldCode="AU" term="%22Delgado-Montes+YA%22">Delgado-Montes YA</searchLink>; Centro Médico Nacional La Raza, Instituto Mexicano del Seguro Social, Ciudad de México, México.<br /><searchLink fieldCode="AU" term="%22Ortiz-Sánchez+E%22">Ortiz-Sánchez E</searchLink>; Subdirección de investigación Básica, Instituto Nacional de Cancerología, Secretaría de Salud, Ciudad de México, México. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229007422%22">Leukemia & lymphoma</searchLink> [Leuk Lymphoma] 2023 Nov-Dec; Vol. 64 (11), pp. 1822-1831. <i>Date of Electronic Publication: </i>2023 Aug 07. – Name: TypePub Label: Publication Type Group: TypPub Data: Meta-Analysis; Systematic Review; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9007422 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1029-2403 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210268022%22">10268022 </searchLink><i>NLM ISO Abbreviation: </i>Leuk Lymphoma <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37548560 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/10428194.2023.2243357 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1822 Titles: – TitleFull: Differences in efficacy and safety among CAR-Ts anti-CD19/CD22, anti-CD19, and anti-CD22, in adult patients with relapse/refractory B-cell acute lymphoblastic leukemia: a meta-analysis and systematic review. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Becerril-Rico J – PersonEntity: Name: NameFull: Delgado-Montes YA – PersonEntity: Name: NameFull: Ortiz-Sánchez E IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 2023 Nov-Dec Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1029-2403 Numbering: – Type: volume Value: 64 – Type: issue Value: 11 Titles: – TitleFull: Leukemia & lymphoma Type: main |
| ResultId | 1 |
